The analysis on glioma patient samples and healthy donors from TCGA and the GTEx database showed that the levels of TMEM60 in glioma were remarkably elevated in GBM and LGC tumor tissues, compared with those in healthy tissues, and this elevated level of TMEM60 was correlated with poor overall survival of patients (Figures 1(a) and 1(b)). The gene discussed is TMEM60; the disease is glioblastoma.